Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer-Reference-Cited by-同舟云学术

Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer

Published:2022-05-27 Issue:5 Volume:3 Page:565-580
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Cheng Chaping,Wang Jinming,Xu Penghui,Zhang Kai,Xin Zhixiang,Zhao Huifang,Ji Zhongzhong,Zhang Man^ORCID,Wang Deng,He Yuman,Jing Na,Fan Liancheng,Liu Kaiyuan,Li Fei,Liu Chengcheng,Gong Yiming,Cui Suli,Sun Zhe,Sun Di,Yao Xinlai,Li Hongjun,Zhang Jian^ORCID,Zhang Pengcheng^ORCID,Dong Baijun^ORCID,Xue Wei,Qian Xueming,Gao Wei-Qiang^ORCID,Zhu Helen He^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s43018-022-00380-3.pdf

Reference51 articles.

1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).

2. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22 (2010).

3. Scher, H. I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187–1197 (2012).

4. Ryan, C. J. et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N. Engl. J. Med. 368, 138–148 (2013).

5. Tran, C. et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 324, 787–790 (2009).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gremlin 1 regulates granulosa cell apoptosis through the TGF-β/SMAD signaling pathway during bovine follicular atresia;Molecular and Cellular Endocrinology;2025-09

2. KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy;Cancer Cell;2025-07

3. Epithelial GREMLIN1 disrupts intestinal epithelial-mesenchymal crosstalk to induce a wnt-dependent ectopic stem cell niche through stromal remodelling;Nature Communications;2025-06-04

4. New insights into Gremlin-1: A tumour microenvironment landscape re-engineer and potential therapeutic target;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2025-06

5. The Role of GREMLIN1, a Bone Morphogenetic Protein Antagonist, in Cancer Stem Cell Regulation;Cells;2025-04-11